DattaU. S.: Corpuscavernosography in conditions other than Peyronie's disease. J. Urol., 118; 588–590 (1977).
3.
FetterT. R., YunenJ. R., DoddG.: Applications of cavernosography in the diagnosis of lesions of the penis. Amer. J. Radiol., 90; 169–175 (1963).
4.
GustafsonM., JohanssonB., EdsmyrFolke: Peyronie's disease: experience of local treatment with Orgotein. Eur. Urol., 7; 346–348 (1981).
5.
HamiltonR. W., SwannJ. C.: Corpuscavernosography in Peyronie's disease. Brit. J. Urol., 39; 409–414 (1967).
6.
Hasche-KlünderR.: Zur Behandlung der Induratio Penis Plastica. Urologe, 3; 335–336 (1970).
7.
La PeraG., FagioliA., MarianiM.: Terapia con Orgoteina nell'induratio penis plastica. Urologia, 50; 465 (1983).
8.
MarbergerH., HuberW. G., BartschG.: Orgotein a new antinflammatory metalloprotein drug. Evaluation of clinical application efficacy and safety in inflammatory conditions of the urinary tract. Intern. Urol. & Nephrol., 6; 61 (1974).
9.
NeyC., MillerH. L., FriendenbergR. M.: Various applications of corpus cavernosography. Radiology, 119; 65 (1976).
10.
PatelliE., MantovaniP., RuoppoloM., AustoniE.: Risultati a tre anni di terapia di jonoforesi con thiomucase nel morbo di La Peyronie. Urologia, 50; 170–174 (1983).
